Top Markets
Coin of the day
BriaCell Therapeutics Corp. BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp.

BCTX
Rang in aandelen #18288
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages... BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
Aandeelprijs
$4.32
Marktkapitalisatie
$8.14M
Verandering (1 dag)
-6.49%
Verandering (1 jaar)
-2.88%
Land
CA
Handel BriaCell Therapeutics Corp. (BCTX)

Categorie

Dividendrendementgeschiedenis voor BriaCell Therapeutics Corp. (BCTX)
Het dividendrendement (TTM) van BriaCell Therapeutics Corp. (aandelsymbool: BCTX) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van BriaCell Therapeutics Corp. (BCTX) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten